ID   EYA4_HUMAN              Reviewed;         639 AA.
AC   O95677; B7Z7F7; O95464; O95679; Q8IW39; Q9NTR7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 2.
DT   12-APR-2017, entry version 152.
DE   RecName: Full=Eyes absent homolog 4;
DE            EC=3.1.3.48 {ECO:0000250|UniProtKB:Q99502};
GN   Name=EYA4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], VARIANT SER-277, AND
RP   ALTERNATIVE SPLICING.
RC   TISSUE=Lens epithelium, and Skeletal muscle;
RX   PubMed=9887327; DOI=10.1093/hmg/8.1.11;
RA   Borsani G., DeGrandi A., Ballabio A., Bulfone A., Bernard L.,
RA   Banfi S., Gattuso C., Mariani M., Dixon M., Donnai D., Metcalfe K.,
RA   Winter R., Robertson M., Axton R., Brown A., van Heyningen V.,
RA   Hanson I.;
RT   "EYA4, a novel vertebrate gene related to Drosophila eyes absent.";
RL   Hum. Mol. Genet. 8:11-23(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN DFNA10.
RX   PubMed=11159937; DOI=10.1093/hmg/10.3.195;
RA   Wayne S., Robertson N.G., DeClau F., Chen N., Verhoeven K., Prasad S.,
RA   Tranebjaerg L., Morton C.C., Ryan A.F., Van Camp G., Smith R.J.H.;
RT   "Mutations in the transcriptional activator EYA4 cause late-onset
RT   deafness at the DFNA10 locus.";
RL   Hum. Mol. Genet. 10:195-200(2001).
RN   [6]
RP   INVOLVEMENT IN CMD1J, AND TISSUE SPECIFICITY.
RX   PubMed=15735644; DOI=10.1038/ng1527;
RA   Schoenberger J., Wang L., Shin J.T., Kim S.D., Depreux F.F.S., Zhu H.,
RA   Zon L., Pizard A., Kim J.B., Macrae C.A., Mungall A.J., Seidman J.G.,
RA   Seidman C.E.;
RT   "Mutation in the transcriptional coactivator EYA4 causes dilated
RT   cardiomyopathy and sensorineural hearing loss.";
RL   Nat. Genet. 37:418-422(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-361, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   INTERACTION WITH SIX3.
RX   PubMed=19606496; DOI=10.1002/humu.21094;
RA   Abe Y., Oka A., Mizuguchi M., Igarashi T., Ishikawa S., Aburatani H.,
RA   Yokoyama S., Asahara H., Nagao K., Yamada M., Miyashita T.;
RT   "EYA4, deleted in a case with middle interhemispheric variant of
RT   holoprosencephaly, interacts with SIX3 both physically and
RT   functionally.";
RL   Hum. Mutat. 30:E946-E955(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-361, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-152 AND ASN-301.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [12]
RP   VARIANT DFNA10 ARG-548.
RX   PubMed=25809937; DOI=10.1038/jhg.2015.19;
RA   Sun Y., Zhang Z., Cheng J., Lu Y., Yang C.L., Luo Y.Y., Yang G.,
RA   Yang H., Zhu L., Zhou J., Yao H.Q.;
RT   "A novel mutation of EYA4 in a large Chinese family with autosomal
RT   dominant middle-frequency sensorineural hearing loss by targeted exome
RT   sequencing.";
RL   J. Hum. Genet. 60:299-304(2015).
RN   [13]
RP   VARIANT DFNA10 ARG-171.
RX   PubMed=25961296; DOI=10.1371/journal.pone.0126602;
RA   Liu F., Hu J., Xia W., Hao L., Ma J., Ma D., Ma Z.;
RT   "Exome sequencing identifies a mutation in EYA4 as a novel cause of
RT   autosomal dominant non-syndromic hearing loss.";
RL   PLoS ONE 10:E0126602-E0126602(2015).
CC   -!- FUNCTION: Tyrosine phosphatase that specifically dephosphorylates
CC       'Tyr-142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation
CC       of histone H2AX plays a central role in DNA repair and acts as a
CC       mark that distinguishes between apoptotic and repair responses to
CC       genotoxic stress. Promotes efficient DNA repair by
CC       dephosphorylating H2AX, promoting the recruitment of DNA repair
CC       complexes containing MDC1. Its function as histone phosphatase
CC       probably explains its role in transcription regulation during
CC       organogenesis. May be involved in development of the eye (By
CC       similarity). {ECO:0000250|UniProtKB:Q99502}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000250|UniProtKB:Q99502}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:O00167};
CC       Note=Binds 1 Mg(2+) ion per subunit.
CC       {ECO:0000250|UniProtKB:O00167};
CC   -!- SUBUNIT: Interacts with SIX3; translocates EYA4 from the cytoplasm
CC       to the nucleus and promotes activation of their target genes.
CC       {ECO:0000269|PubMed:19606496}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q99502}.
CC       Nucleus {ECO:0000250|UniProtKB:Q99502}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O95677-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95677-2; Sequence=VSP_001495, VSP_001496;
CC       Name=3;
CC         IsoId=O95677-3; Sequence=VSP_001497, VSP_001498;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=4;
CC         IsoId=O95677-4; Sequence=VSP_001499;
CC       Name=5;
CC         IsoId=O95677-5; Sequence=VSP_042160, VSP_001499;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart and skeletal muscle.
CC       {ECO:0000269|PubMed:15735644}.
CC   -!- DISEASE: Deafness, autosomal dominant, 10 (DFNA10) [MIM:601316]: A
CC       form of non-syndromic sensorineural hearing loss. Sensorineural
CC       deafness results from damage to the neural receptors of the inner
CC       ear, the nerve pathways to the brain, or the area of the brain
CC       that receives sound information. {ECO:0000269|PubMed:11159937,
CC       ECO:0000269|PubMed:25809937, ECO:0000269|PubMed:25961296}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Cardiomyopathy, dilated 1J (CMD1J) [MIM:605362]: A
CC       disorder characterized by ventricular dilation and impaired
CC       systolic function, resulting in congestive heart failure and
CC       arrhythmia. Patients are at risk of premature death. CMD1J is
CC       characterized by the association of sensorineural hearing loss and
CC       dilated cardiomyopathy in the absence of other anomalies.
CC       {ECO:0000269|PubMed:15735644}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the HAD-like hydrolase superfamily. EYA
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y17114; CAA76636.1; -; mRNA.
DR   EMBL; Y17847; CAA76891.1; -; Genomic_DNA.
DR   EMBL; AJ007993; CAA07816.1; -; mRNA.
DR   EMBL; AJ007994; CAA07817.1; -; mRNA.
DR   EMBL; AK301950; BAH13593.1; -; mRNA.
DR   EMBL; AL121959; CAB92069.2; -; Genomic_DNA.
DR   EMBL; AL024497; CAB92069.2; JOINED; Genomic_DNA.
DR   EMBL; AL450270; CAB92069.2; JOINED; Genomic_DNA.
DR   EMBL; AL024497; CAI42524.1; -; Genomic_DNA.
DR   EMBL; AL121959; CAI42524.1; JOINED; Genomic_DNA.
DR   EMBL; AL450270; CAI42524.1; JOINED; Genomic_DNA.
DR   EMBL; AL450270; CAI41272.1; -; Genomic_DNA.
DR   EMBL; AL024497; CAI41272.1; JOINED; Genomic_DNA.
DR   EMBL; AL121959; CAI41272.1; JOINED; Genomic_DNA.
DR   EMBL; BC041063; AAH41063.1; -; mRNA.
DR   CCDS; CCDS43506.1; -. [O95677-2]
DR   CCDS; CCDS5165.1; -. [O95677-1]
DR   CCDS; CCDS5166.1; -. [O95677-4]
DR   CCDS; CCDS75523.1; -. [O95677-5]
DR   RefSeq; NP_001287941.1; NM_001301012.1. [O95677-5]
DR   RefSeq; NP_001287942.1; NM_001301013.1.
DR   RefSeq; NP_004091.3; NM_004100.4. [O95677-1]
DR   RefSeq; NP_742101.2; NM_172103.3. [O95677-2]
DR   RefSeq; NP_742103.1; NM_172105.3. [O95677-4]
DR   UniGene; Hs.596680; -.
DR   ProteinModelPortal; O95677; -.
DR   SMR; O95677; -.
DR   BioGrid; 108382; 4.
DR   IntAct; O95677; 1.
DR   STRING; 9606.ENSP00000347294; -.
DR   DEPOD; O95677; -.
DR   iPTMnet; O95677; -.
DR   PhosphoSitePlus; O95677; -.
DR   BioMuta; EYA4; -.
DR   MaxQB; O95677; -.
DR   PaxDb; O95677; -.
DR   PeptideAtlas; O95677; -.
DR   PRIDE; O95677; -.
DR   DNASU; 2070; -.
DR   Ensembl; ENST00000355167; ENSP00000347294; ENSG00000112319. [O95677-4]
DR   Ensembl; ENST00000355286; ENSP00000347434; ENSG00000112319. [O95677-2]
DR   Ensembl; ENST00000367895; ENSP00000356870; ENSG00000112319. [O95677-1]
DR   Ensembl; ENST00000431403; ENSP00000404558; ENSG00000112319. [O95677-4]
DR   Ensembl; ENST00000452339; ENSP00000395916; ENSG00000112319. [O95677-5]
DR   GeneID; 2070; -.
DR   KEGG; hsa:2070; -.
DR   UCSC; uc003qec.5; human. [O95677-1]
DR   CTD; 2070; -.
DR   DisGeNET; 2070; -.
DR   GeneCards; EYA4; -.
DR   GeneReviews; EYA4; -.
DR   HGNC; HGNC:3522; EYA4.
DR   HPA; HPA004805; -.
DR   HPA; HPA038771; -.
DR   HPA; HPA038772; -.
DR   MalaCards; EYA4; -.
DR   MIM; 601316; phenotype.
DR   MIM; 603550; gene.
DR   MIM; 605362; phenotype.
DR   neXtProt; NX_O95677; -.
DR   OpenTargets; ENSG00000112319; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   Orphanet; 217622; Sensorineural deafness with dilated cardiomyopathy.
DR   PharmGKB; PA27934; -.
DR   eggNOG; KOG3107; Eukaryota.
DR   eggNOG; ENOG410XT12; LUCA.
DR   GeneTree; ENSGT00390000008860; -.
DR   HOGENOM; HOG000293149; -.
DR   HOVERGEN; HBG002447; -.
DR   InParanoid; O95677; -.
DR   KO; K17622; -.
DR   PhylomeDB; O95677; -.
DR   TreeFam; TF319337; -.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   GeneWiki; EYA4; -.
DR   GenomeRNAi; 2070; -.
DR   PRO; PR:O95677; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112319; -.
DR   CleanEx; HS_EYA4; -.
DR   ExpressionAtlas; O95677; baseline and differential.
DR   Genevisible; O95677; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IBA:GO_Central.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0016576; P:histone dephosphorylation; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IBA:GO_Central.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   InterPro; IPR028478; EYA4.
DR   InterPro; IPR006545; EYA_dom.
DR   InterPro; IPR028472; EYA_fam.
DR   PANTHER; PTHR10190; PTHR10190; 1.
DR   PANTHER; PTHR10190:SF20; PTHR10190:SF20; 1.
DR   TIGRFAMs; TIGR01658; EYA-cons_domain; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Cardiomyopathy;
KW   Chromatin regulator; Complete proteome; Cytoplasm; Deafness;
KW   Developmental protein; Disease mutation; DNA damage; DNA repair;
KW   Hydrolase; Magnesium; Metal-binding; Non-syndromic deafness; Nucleus;
KW   Phosphoprotein; Polymorphism; Protein phosphatase; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    639       Eyes absent homolog 4.
FT                                /FTId=PRO_0000218651.
FT   ACT_SITE    375    375       Nucleophile.
FT                                {ECO:0000250|UniProtKB:O00167}.
FT   ACT_SITE    377    377       Proton donor.
FT                                {ECO:0000250|UniProtKB:O00167}.
FT   METAL       375    375       Magnesium.
FT                                {ECO:0000250|UniProtKB:O00167}.
FT   METAL       377    377       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:O00167}.
FT   METAL       603    603       Magnesium.
FT                                {ECO:0000250|UniProtKB:O00167}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     361    361       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      70    123       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042160.
FT   VAR_SEQ      70     92       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001495.
FT   VAR_SEQ      93     93       M -> V (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001496.
FT   VAR_SEQ     447    452       STYSFA -> RCKRRG (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_001497.
FT   VAR_SEQ     453    639       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_001498.
FT   VAR_SEQ     589    613       MQRFGRKVVYVVIGDGVEEEQAAKK -> VSRFGTNITYVV
FT                                IGDGRDEEHAANQ (in isoform 4 and isoform
FT                                5). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_001499.
FT   VARIANT     152    152       L -> R (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036248.
FT   VARIANT     171    171       G -> R (in DFNA10).
FT                                {ECO:0000269|PubMed:25961296}.
FT                                /FTId=VAR_074570.
FT   VARIANT     277    277       G -> S (in dbSNP:rs9493627).
FT                                {ECO:0000269|PubMed:9887327}.
FT                                /FTId=VAR_022932.
FT   VARIANT     301    301       D -> N (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs779172192).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036249.
FT   VARIANT     548    548       T -> R (in DFNA10).
FT                                {ECO:0000269|PubMed:25809937}.
FT                                /FTId=VAR_074571.
FT   CONFLICT    177    177       V -> A (in Ref. 2; BAH13593).
FT                                {ECO:0000305}.
SQ   SEQUENCE   639 AA;  69505 MW;  CC59A8FB1527A0EC CRC64;
     MEDSQDLNEQ SVKKTCTESD VSQSQNSRSM EMQDLASPHT LVGGGDTPGS SKLEKSNLSS
     TSVTTNGTGG ENMTVLNTAD WLLSCNTPSS ATMSLLAVKT EPLNSSETTA TTGDGALDTF
     TGSVITSSGY SPRSAHQYSP QLYPSKPYPH ILSTPAAQTM SAYAGQTQYS GMQQPAVYTA
     YSQTGQPYSL PTYDLGVMLP AIKTESGLSQ TQSPLQSGCL SYSPGFSTPQ PGQTPYSYQM
     PGSSFAPSST IYANNSVSNS TNFSGSQQDY PSYTAFGQNQ YAQYYSASTY GAYMTSNNTA
     DGTPSSTSTY QLQESLPGLT NQPGEFDTMQ SPSTPIKDLD ERTCRSSGSK SRGRGRKNNP
     SPPPDSDLER VFVWDLDETI IVFHSLLTGS YAQKYGKDPP MAVTLGLRME EMIFNLADTH
     LFFNDLEECD QVHIDDVSSD DNGQDLSTYS FATDGFHAAA SSANLCLPTG VRGGVDWMRK
     LAFRYRRVKE LYNTYKNNVG GLLGPAKRDA WLQLRAEIEG LTDSWLTNAL KSLSIISTRS
     NCINVLVTTT QLIPALAKVL LYSLGGAFPI ENIYSATKIG KESCFERIMQ RFGRKVVYVV
     IGDGVEEEQA AKKHNMPFWR ISSHSDLLAL HQALELEYL
//
